ADVFN - ニュース

S&P 500

5,477.90

0.16%

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/27	05 : 13	PR Newswire (US)	Simmons First National Corporation Announces Second Quarter 2024 Earnings Release Date and Conference Call	NASDAQ:SFNC	Simmons First National Corporation
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:FBGX	UBS AG FI Enhanced Large Cap Growth
2024/06/27	05 : 12	Business Wire	Moen Announces Agreement with California Water Efficiency Partnership	NYSE:FBIN	Fortune Brands Innovations Inc
2024/06/27	05 : 12	PR Newswire (US)	Republic of Peru Announces Results of Exchange and Tender Offers
2024/06/27	05 : 11	Business Wire	2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million	NASDAQ:TSVT	2seventy bio Inc